Home » FDA to Centralize Enforcement, Specialize Workforce
FDA to Centralize Enforcement, Specialize Workforce
The FDA will create a pharma-only enforcement unit that promises more consistent inspections and enforcement decisions with fewer bureaucratic hurdles for investigators to issue warning letters.
Drug GMP Report
Drugs Regulatory AffairsDrug GMP Report
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May